February 28, 2022Biomedicine & PharmacotherapyOpen Access

Acute coronary syndromes in diabetic patients, outcome, revascularization, and antithrombotic therapy

View Full Paper

Ask AI

Bookmark

Why the study?

Despite advances in revascularization techniques and potent antiplatelet agents, diabetic patients with ACS continue to experience worse outcomes than non-diabetics, and the optimal revascularization strategy in multivessel or complex CAD remains unclear.

Population

Patients with acute coronary syndrome and diabetes

Design

Review

Authors

EBElena Emilia BabeşUniversity of Oradea CBCristiana BusteaUniversity of Oradea TBTapan BehlUniversity of Delhi

Discussion

Member takes

Implication

Provides updated synthesis for diabetic ACS care; leaves open optimal revascularization and antithrombotic strategies.

Structured PICO

Population

Patients with acute coronary syndrome (ACS) and diabetes

Intervention

Revascularization strategies (PCI, CABG) and antithrombotic therapy (e.g., prasugrel, ticagrelor)

This review summarizes the evidence on the pathophysiology, prognosis, revascularization strategies, and antithrombotic therapies for diabetic patients presenting with acute coronary syndromes.

Cite This Study

Babeş et al. (2022) studied this question.

synapsesocial.com/papers/69f7e2d2b3779c4692289013 https://doi.org/10.1016/j.biopha.2022.112772

Topics

Percutaneous coronary intervention STEMI management

View Full Paper

Ask AI

Bookmark

Acute coronary syndromes in diabetic patients, outcome, revascularization, and antithrombotic therapy

Discussion

Member takes

Implication

Structured PICO

Cite This Study

Topics

Acute coronary syndromes in diabetic patients, outcome, revascularization, and antithrombotic therapy

Discussion

Member takes

Implication

Structured PICO

Cite This Study

Also Consider

Topics

Also Consider